AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $214,000 | -38.0% | 41,387 | +14.2% | 0.00% | -100.0% |
| Q4 2015 | $345,000 | +17.7% | 36,230 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $293,000 | -49.5% | 35,602 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $580,000 | +1.9% | 35,702 | +154.0% | 0.00% | 0.0% |
| Q1 2015 | $569,000 | -17.4% | 14,054 | +10.2% | 0.00% | -50.0% |
| Q4 2014 | $689,000 | +58.8% | 12,754 | +0.4% | 0.00% | +100.0% |
| Q3 2014 | $434,000 | – | 12,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|